Cover Image
市場調查報告書

美容設備:醫療設備的開發平台評估

Aesthetic Devices - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 351351
出版日期 內容資訊 英文 358 Pages
訂單完成後即時交付
價格
Back to Top
美容設備:醫療設備的開發平台評估 Aesthetic Devices - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年10月01日 內容資訊: 英文 358 Pages
簡介

本報告提供美容設備的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 美容設備概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 美容設備 - 正在開發的開發中產品:各企業

  • 開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 美容設備的開發企業與產品概要

  • Advalight
  • Aesthetic Medical Device
  • Aesthetics Point Ltd.
  • AirXpanders, Inc.
  • Allergan, Inc.
  • Ambicare Health Ltd
  • Andrew Technology, LLC
  • Anika Therapeutics, Inc.
  • Avita Medical Ltd
  • BioPhotas, Inc.
  • BioPolymer GmbH & Co. KG
  • Biosculpture Technology, Inc.
  • Body Organ Biomedical Corp.
  • Chromogenex Technologies Limited
  • Cozart plc
  • Cynosure, Inc.
  • Cytophil, Inc.
  • Cytori Therapeutics, Inc.
  • Cytosial Biomedic, S.a.s.
  • Dermele Skin Care, LLC
  • Ellman International, Inc.
  • Erchonia Corporation
  • Eternity Healthcare Inc.
  • EternoGen, LLC
  • Eve Aesthetics Ltd.
  • FibroGen, Inc.
  • Forticell Bioscience, Inc.
  • Genethia Phrima SRL
  • Genzyme Corporation
  • Ilooda Co., Ltd.
  • ImpLite Ltd.
  • Innovia LLC
  • Invasix
  • Juvenis Ltd.
  • Keraderm LLC
  • Khorionyx
  • L&C Bio
  • Medifirst Solutions, Inc.
  • Medixsysteme
  • Mentor Worldwide LLC
  • Merz Pharma GmbH & Co. KgaA
  • Moma Therapeutics, Inc.
  • Mosaic Medical Technologies, Inc
  • Neosthetic, LLC
  • NivaSonix, LLC
  • Northwestern University
  • Northwood Medical Innovation Limited
  • Nu Skin International Inc.
  • Oligo Medic, Inc.
  • ORGEV Laboratories
  • Osyris Medical
  • Philips Healthcare
  • PhotoDerma SA
  • PhotoMedex, Inc.
  • Pinnacle Therapeutics
  • PolyNovo Biomaterials Pty Ltd
  • PS Advanced Engineering
  • Rocky Mountain Biosystems Inc
  • SANUWAVE Health, Inc.
  • Sebacia Inc.
  • Sekisui Medical Co., Ltd.
  • SharpLight
  • Shin Poong Pharm.Co., Ltd.
  • Sinclair IS Pharma Plc
  • Slender Medical Ltd.
  • Suneva Medical, Inc.
  • Sybaritic, Inc.
  • Syneron Medical Ltd.
  • TEI Biosciences, Inc.
  • ThermiAesthetics
  • University of California, Irvine
  • Valeant Pharmaceuticals Ltd
  • Yolo Medical Inc.

第6章 美容設備 - 最近的事件

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0455EPD

GlobalData's Medical Devices sector report, "Aesthetic Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Aesthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Aesthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 16

2 Introduction 17

  • 2.1 Aesthetic Devices Overview 17

3 Products under Development 18

  • 3.1 Aesthetic Devices - Pipeline Products by Stage of Development 18
  • 3.2 Aesthetic Devices - Pipeline Products by Segment 19
  • 3.3 Aesthetic Devices - Pipeline Products by Territory 20
  • 3.4 Aesthetic Devices - Pipeline Products by Regulatory Path 21
  • 3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
  • 3.6 Aesthetic Devices - Ongoing Clinical Trials 23

4 Aesthetic Devices - Pipeline Products under Development by Companies 24

  • 4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development 24
  • 4.2 Aesthetic Devices - Pipeline Products by Stage of Development 27

5 Aesthetic Devices Companies and Product Overview 31

  • 5.1 Acelity L.P. Inc. Company Overview 31
  • 5.2 Aeon Astron Corporation Company Overview 32
  • 5.3 Aesthetic Medical Device Company Overview 33
  • 5.4 Aesthetics Point Ltd. Company Overview 35
  • 5.5 Allergan Inc Company Overview 36
  • 5.6 Allergan Plc Company Overview 43
  • 5.7 Almirall Ltd Company Overview 46
  • 5.8 Ambicare Health Ltd Company Overview 47
  • 5.9 Andrew Technology LLC Company Overview 48
  • 5.10 Anika Therapeutics Inc Company Overview 49
  • 5.11 Apogee Aesthetic Technologies Company Overview 50
  • 5.12 Avita Medical Ltd Company Overview 51
  • 5.13 Bellus Medical, LLC Company Overview 54
  • 5.14 BioPhotas, Inc. Company Overview 58
  • 5.15 Biosculpture Technology, Inc. Company Overview 59
  • 5.16 BioTime Inc Company Overview 61
  • 5.17 Bioxis Pharmaceuticals Company Overview 65
  • 5.18 Celltrix AB Company Overview 68
  • 5.19 Cutera Inc Company Overview 69
  • 5.20 Cytophil, Inc. Company Overview 74
  • 5.21 Cytori Therapeutics Inc Company Overview 75
  • 5.22 Cytrellis Biosystems Inc Company Overview 76
  • 5.23 Dermele Skin Care, LLC Company Overview 77
  • 5.24 Eclipse Aesthetics LLC Company Overview 78
  • 5.25 Ellman International Inc Company Overview 80
  • 5.26 Energist Ltd Company Overview 81
  • 5.27 Erchonia Corp Company Overview 82
  • 5.28 Eternity Healthcare Inc. Company Overview 83
  • 5.29 EternoGen Aesthetics LLC Company Overview 84
  • 5.30 FibroGen Inc Company Overview 85
  • 5.31 Forticell Bioscience Inc Company Overview 86
  • 5.32 Fourth State Medicine Ltd Company Overview 87
  • 5.33 Galderma SA Company Overview 88
  • 5.34 Genethia Phrima SRL Company Overview 95
  • 5.35 Genzyme Corp Company Overview 96
  • 5.36 Hologic Inc Company Overview 97
  • 5.37 ImpLite Ltd. Company Overview 98
  • 5.38 Innovia LLC Company Overview 99
  • 5.39 IonMed Ltd. Company Overview 101
  • 5.40 Juvenis Ltd Company Overview 102
  • 5.41 Keraderm LLC Company Overview 103
  • 5.42 Khorionyx SA Company Overview 104
  • 5.43 L&C Bio Company Overview 105
  • 5.44 Medifirst Solutions Inc Company Overview 106
  • 5.45 Medixsysteme Company Overview 107
  • 5.46 Mentor Worldwide LLC Company Overview 110
  • 5.47 Merz Pharma GmbH & Co KgaA Company Overview 111
  • 5.48 Moma Therapeutics, Inc. Company Overview 113
  • 5.49 Mosaic Medical Technologies, Inc Company Overview 114
  • 5.50 NanoVibronix Inc Company Overview 115
  • 5.51 Neosthetic, LLC Company Overview 116
  • 5.52 NivaSonix, LLC Company Overview 117
  • 5.53 Northwestern University Company Overview 118
  • 5.54 Nu Skin International Inc. Company Overview 119
  • 5.55 Oligo Medic, Inc. Company Overview 121
  • 5.56 ORGEV Laboratories Company Overview 122
  • 5.57 PetVivo Holdings Inc Company Overview 124
  • 5.58 PhotoDerma SA Company Overview 126
  • 5.59 PhotoMedex Inc Company Overview 128
  • 5.60 PhotoSonix Medical, Inc. Company Overview 131
  • 5.61 Pinnacle Therapeutics Company Overview 132
  • 5.62 PolyNovo Biomaterials Pty Ltd Company Overview 133
  • 5.63 PS Advanced Engineering Company Overview 136
  • 5.64 SANUWAVE Health Inc Company Overview 138
  • 5.65 Sebacia Inc Company Overview 141
  • 5.66 Sekisui Medical Co Ltd Company Overview 144
  • 5.67 Serene Medical, Inc. Company Overview 145
  • 5.68 Shanghai Haohai Biological Technology Co Ltd Company Overview 146
  • 5.69 SharpLight Company Overview 148
  • 5.70 Shin Poong PharmCo Ltd Company Overview 150
  • 5.71 Sienna Biopharmaceuticals Inc Company Overview 151
  • 5.72 Sinclair Pharma PLC Company Overview 154
  • 5.73 Slender Medical Ltd. Company Overview 165
  • 5.74 Sofregen Medical Inc Company Overview 167
  • 5.75 Southern Illinois University Carbondale Company Overview 168
  • 5.76 Stratpharma AG Company Overview 169
  • 5.77 Suneva Medical Inc Company Overview 170
  • 5.78 Sybaritic Inc Company Overview 173
  • 5.79 Syneron Medical Ltd Company Overview 174
  • 5.80 TEI Biosciences Inc Company Overview 179
  • 5.81 University of California Irvine Company Overview 180
  • 5.82 University of California Santa Barbara Company Overview 181
  • 5.83 Valeant Pharmaceuticals International Inc Company Overview 182
  • 5.84 Zeltiq Aesthetics Inc Company Overview 187

6 Aesthetic Devices- Recent Developments 190

  • 6.1 Sep 01, 2017: Prollenium Medical Technologies Announces the Appointment of its New President of US Operations, Sean L. Wilson 190
  • 6.2 Aug 31, 2017: Avita Medical Names Erin Liberto as Chief Commercial Officer 190
  • 6.3 Aug 30, 2017: New Study: iGrow Plus Minoxidil Accelerates Hair Growth 190
  • 6.4 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 191
  • 6.5 Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer 192
  • 6.6 Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results 193
  • 6.7 Aug 21, 2017: Cutera Strengthens Leadership Team with Two Key Executive Appointments 194
  • 6.8 Aug 18, 2017: Cutera Announces Retirement of Jerry P. Widman as Member of the Board of Directors 194
  • 6.9 Aug 17, 2017: Prollenium Medical Technologies announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler 195
  • 6.10 Aug 14, 2017: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update 195
  • 6.11 Aug 10, 2017: Cytori Reports Second Quarter 2017 Business and Financial Results 197
  • 6.12 Aug 10, 2017: AirXpanders: Half-Yearly Report 198
  • 6.13 Aug 08, 2017: Penumbra Reports Second Quarter 2017 Financial Results 199
  • 6.14 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 199
  • 6.15 Aug 08, 2017: Medifirst Appoints Executive Advisor for China 202
  • 6.16 Aug 07, 2017: FibroGen Reports Second Quarter 2017 Financial Results 203
  • 6.17 Aug 07, 2017: Cutera Reports Second Quarter 2017 Financial Performance, Increases Revenue and EPS Guidance 204
  • 6.18 Aug 04, 2017: Medifirst Solutions Signs Distribution Agreement 205
  • 6.19 Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 205
  • 6.20 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 206
  • 6.21 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 207
  • 6.22 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 210
  • 6.23 Jul 27, 2017: Quantel: First-Half Revenues Up 4.8% 211
  • 6.24 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 212
  • 6.25 Jul 25, 2017: Histogen's Growth Factor Technology to be Marketed as Part of Allergan Skin Care Line 213
  • 6.26 Jul 19, 2017: Merz To Consolidate Operations in Racine County, Create Up To 20 Jobs 213
  • 6.27 Jul 12, 2017: Cutera Announces Engagement of Sandy Gardiner as Consultant CFO 214
  • 6.28 Jul 11, 2017: CE Mark Signals Expansion of SkinPen Microneedling System to Europe 214
  • 6.29 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 215
  • 6.30 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 215
  • 6.31 Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 216
  • 6.32 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer 217
  • 6.33 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 217

7 Appendix 353

  • 7.1 Methodology 353
  • 7.2 About GlobalData 356
  • 7.3 Contact Us 356
  • 7.4 Disclaimer 356

List of Tables

1.1 List of Tables

  • Table 1: Aesthetic Devices - Pipeline Products by Stage of Development 20
  • Table 2: Aesthetic Devices - Pipeline Products by Segment 21
  • Table 3: Aesthetic Devices - Pipeline Products by Territory 22
  • Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
  • Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 24
  • Table 6: Aesthetic Devices - Ongoing Clinical Trials 25
  • Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development 26
  • Table 8: Aesthetic Devices - Pipeline Products by Stage of Development 29
  • Table 9: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 10: Strattice For Facelift - Product Status 33
  • Table 11: Strattice For Facelift - Product Description 33
  • Table 12: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 13: BioDermal Filler - Product Status 34
  • Table 14: BioDermal Filler - Product Description 34
  • Table 15: Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 16: Alluris - Product Status 35
  • Table 17: Alluris - Product Description 35
  • Table 18: Skinlumina - Product Status 36
  • Table 19: Skinlumina - Product Description 36
  • Table 20: Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 21: Juvence Implant - Product Status 37
  • Table 22: Juvence Implant - Product Description 37
  • Table 23: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 24: Eplica Silk - Product Status 38
  • Table 25: Eplica Silk - Product Description 38
  • Table 26: JUVEDERM Volbella - Product Status 39
  • Table 27: JUVEDERM Volbella - Product Description 39
  • Table 28: Juvederm Vollure XC - Product Status 39
  • Table 29: Juvederm Vollure XC - Product Description 40
  • Table 30: Juvederm VOLUMA XC - Product Status 40
  • Table 31: Juvederm VOLUMA XC - Product Description 40
  • Table 32: SeriGel - Product Status 41
  • Table 33: SeriGel - Product Description 41
  • Table 34: Allergan Inc - Ongoing Clinical Trials Overview 42
  • Table 35: Juvederm VOLUMA XC - Clinical Study of Neuramis Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume 43
  • Table 36: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 43
  • Table 37: Juvederm Vollure XC - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 44
  • Table 38: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 39: earFold - Product Status 45
  • Table 40: earFold - Product Description 45
  • Table 41: Allergan Plc - Ongoing Clinical Trials Overview 46
  • Table 42: earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD 47
  • Table 43: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 44: Hyaluronic Acid Facial Filler - Product Status 48
  • Table 45: Hyaluronic Acid Facial Filler - Product Description 48
  • Table 46: Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 47: Ambulight Rejuvenate - Product Status 49
  • Table 48: Ambulight Rejuvenate - Product Description 49
  • Table 49: Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 50: HydraSolve Lipoplasty System - Visceral Fat - Product Status 50
  • Table 51: HydraSolve Lipoplasty System - Visceral Fat - Product Description 50
  • Table 52: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 53: Next Generation ELEVESS Dermal Filler - Product Status 51
  • Table 54: Next Generation ELEVESS Dermal Filler - Product Description 51
  • Table 55: Apogee Aesthetic Technologies Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 56: G-Lift - Product Status 52
  • Table 57: G-Lift - Product Description 52
  • Table 58: Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 59: ReNovaCell - Aesthetics And Repigmentation - Product Status 53
  • Table 60: ReNovaCell - Aesthetics And Repigmentation - Product Description 53
  • Table 61: Avita Medical Ltd - Ongoing Clinical Trials Overview 54
  • Table 62: ReNovaCell - Aesthetics And Repigmentation - Autologous Cell Suspension Grafting Using ReNovacell in Non-segmental Vitiligo Patients: A Randomized Controlled Study 55
  • Table 63: ReNovaCell - Aesthetics And Repigmentation - Evaluation of Optimal Deployment of ReNovaCell in Subjects with Pigmentation Defects 55
  • Table 64: Bellus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 65: SkinPen Microneedling Cartridge - Product Status 56
  • Table 66: SkinPen Microneedling Cartridge - Product Description 56
  • Table 67: SkinPen Precision Microneedling Pen - Product Status 57
  • Table 68: SkinPen Precision Microneedling Pen - Product Description 57
  • Table 69: Bellus Medical, LLC - Ongoing Clinical Trials Overview 58
  • Table 70: SkinPen Microneedling Cartridge - A Single-center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Acne Scars on the Face and/or Back 59
  • Table 71: BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 72: Celluma - Skin Rejuvenation And Sun Spots - Product Status 60
  • Table 73: Celluma - Skin Rejuvenation And Sun Spots - Product Description 60
  • Table 74: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 75: Airbrush Liposculptor IIE - Product Status 61
  • Table 76: Airbrush Liposculptor IIE - Product Description 61
  • Table 77: Airbrush Liposculptor IIIE - Product Status 62
  • Table 78: Airbrush Liposculptor IIIE - Product Description 62
  • Table 79: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 80: Renevia - Product Status 63
  • Table 81: Renevia - Product Description 64
  • Table 82: BioTime Inc - Ongoing Clinical Trials Overview 65
  • Table 83: Renevia - A Randomized, Evaluator-blinded, Delayed-treatment-controlled Study of the Effectiveness and Safety of Renevia, A Resorbable Matrix for the Delivery of Autologous Adipose Derived Cells to treat Subcutaneous Facial Lipoatrophy Defects Arising from HIV 66
  • Table 84: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 85: Cytosial - Product Status 67
  • Table 86: Cytosial - Product Description 67
  • Table 87: Cytosmile - Product Status 68
  • Table 88: Cytosmile - Product Description 68
  • Table 89: MTI-12 - Product Status 68
  • Table 90: MTI-12 - Product Description 69
  • Table 91: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 92: Credurance - Product Status 70
  • Table 93: Credurance - Product Description 70
  • Table 94: Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 95: enlighten 670nm Laser - Skin Rejuvenation - Product Status 71
  • Table 96: enlighten 670nm Laser - Skin Rejuvenation - Product Description 71
  • Table 97: enlighten 670nm Laser - Tattoo Removal - Product Status 72
  • Table 98: enlighten 670nm Laser - Tattoo Removal - Product Description 72
  • Table 99: Cutera Inc - Ongoing Clinical Trials Overview 73
  • Table 100: enlighten 670nm Laser - Skin Rejuvenation - Study of a Novel Laser for Skin Rejuvenation 74
  • Table 101: enlighten 670nm Laser - Tattoo Removal - An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal 75
  • Table 102: Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 103: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status 76
  • Table 104: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description 76
  • Table 105: Cytori Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 106: Celution - Parry-Romberg's Disease - Product Status 77
  • Table 107: Celution - Parry-Romberg's Disease - Product Description 77
  • Table 108: Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 109: Aesthetic Device - Product Status 78
  • Table 110: Aesthetic Device - Product Description 78
  • Table 111: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 112: Gold Nanoparticle Dermal Filler - Product Status 79
  • Table 113: Gold Nanoparticle Dermal Filler - Product Description 79
  • Table 114: Eclipse Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 115: Eclipse MicroPen Evo - Product Status 80
  • Table 116: Eclipse MicroPen Evo - Product Description 80
  • Table 117: Eclipse Reverse - Product Status 81
  • Table 118: Eclipse Reverse - Product Description 81
  • Table 119: Ellman International Inc Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 120: Radiage Wand RF Non-Ablative Handpiece - 15mm - Product Status 82
  • Table 121: Radiage Wand RF Non-Ablative Handpiece - 15mm - Product Description 82
  • Table 122: Energist Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 123: i-LipoXcell - Radiofrequency Skin Tightening - Product Status 83
  • Table 124: i-LipoXcell - Radiofrequency Skin Tightening - Product Description 83
  • Table 125: Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 126: Low Level Laser - Hair Restoration - Product Status 84
  • Table 127: Low Level Laser - Hair Restoration - Product Description 84
  • Table 128: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 129: Hand-held Laser Hair Removal Device - Product Status 85
  • Table 130: Hand-held Laser Hair Removal Device - Product Description 85
  • Table 131: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 132: Collagen Scaffold - Aesthetic Procedures - Product Status 86
  • Table 133: Collagen Scaffold - Aesthetic Procedures - Product Description 86
  • Table 134: FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 135: FG-5030 - Product Status 87
  • Table 136: FG-5030 - Product Description 87
  • Table 137: Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 138: Haptized Collagen Tissue Augmentation - Product Status 88
  • Table 139: Haptized Collagen Tissue Augmentation - Product Description 88
  • Table 140: Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 141: Nebulaskin - Product Status 89
  • Table 142: Nebulaskin - Product Description 89
  • Table 143: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 144: Restylane Lidocaine - Product Status 90
  • Table 145: Restylane Lidocaine - Product Description 90
  • Table 146: Restylane Lyft - Hand Rejuvenation - Product Status 91
  • Table 147: Restylane Lyft - Hand Rejuvenation - Product Description 91
  • Table 148: Restylane Perlane - Product Status 91
  • Table 149: Restylane Perlane - Product Description 92
  • Table 150: Restylane Skinboosters Vital - Product Status 92
  • Table 151: Restylane Skinboosters Vital - Product Description 92
  • Table 152: Galderma SA - Ongoing Clinical Trials Overview 93
  • Table 153: Restylane Perlane - A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency 94
  • Table 154: Restylane Perlane - A Randomized, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate with Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane 94

List of Figures

1.2 List of Figures

  • Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development 20
  • Figure 2: Aesthetic Devices - Pipeline Products by Segment 21
  • Figure 3: Aesthetic Devices - Pipeline Products by Territory 22
  • Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
  • Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 24
  • Figure 6: Aesthetic Devices - Ongoing Clinical Trials 25
Back to Top